Salmeterol, a component of WIXELA INHUB, can produce a clinically significant cardiovascular effect in some patients as measured by pulse rate, blood pressure, and/or symptoms. If such effects occur, WIXELA INHUB may need to be discontinued. WIXELA..
Relevance: 78.55456